STOCK TITAN

NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207

Alto Neuroscience will discuss a $120 million private placement to advance development of its psychiatric candidate ALTO-207 on NYSE Live on March 23, 2026.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Alto Neuroscience will discuss a $120 million private placement to advance development of its psychiatric candidate ALTO-207 on NYSE Live on March 23, 2026. Nick Smith, Alto CFO, will appear on NYSE Live to explain the financing and its intended use.

The NYSE pre-market update for March 23, 2026 also covers market movement after postponed strikes on Iran, an AI-at-work KPMG survey, RSAC conference coverage, and corporate notes including Copa Airlines (NYSE: CPA) and Jacobs (NYSE: J).

Loading...
Loading translation...

Positive

  • $120 million private placement to fund ALTO-207 development
  • CFO media appearance on NYSE Live increases investor visibility

Negative

  • None.
Argus Mar 23 session
+4.04% close to close Open Argus
Details

News Market Reaction – CPA

On Mar 23, the day this news came out, CPA closed 4.04% above the previous close.

Data tracked by StockTitan Argus for the Mar 23 session.

Key Figures

Private placement size: $120 million Listing anniversary: 20th Leadership attendees: 180 leaders
Private placement size
$120 million
Alto Neuroscience financing to fund ALTO-207 development
Listing anniversary
20th
Copa Airlines NYSE listing anniversary celebrated at Opening Bell
Leadership attendees
180 leaders
Jacobs’ global executive leadership team meeting in Midtown

Historical Context

5 past events · Latest: Mar 16
5 events
  1. Mar 16

    Traffic statistics

    24h Move
    +2.3%

    February 2026 traffic showed double‑digit ASM and RPM growth with higher load factor.

  2. Feb 26

    Annual report filing

    24h Move
    -6.4%

    Form 20‑F filing provided audited 2025 financials and access to detailed disclosures.

  3. Feb 11

    Earnings results

    24h Move
    -0.1%

    Reported strong 4Q25 and 2025 net profit with solid margins and a US$1.71 dividend.

  4. Feb 09

    Traffic statistics

    24h Move
    -0.1%

    January 2026 metrics showed ASM and RPM growth with higher system load factor.

  5. Jan 13

    Traffic statistics

    24h Move
    -4.2%

    December 2025 traffic data indicated continued demand recovery and improved seat utilization.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

private placement
1 terms
private placement financial
"company's $120 million in private placement financing to help advance its mission"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, March 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on March 23rd

  • Stocks jump and oil retreats after President Donald Trump postpones strikes on Iran energy targets with ceasefire talks beginning.
  • Alto Neuroscience CFO Nick Smith will join NYSE Live to discuss the company's $120 million in private placement financing to help advance its mission of matching patients with the right psychiatric medications.
  • An executive from KPMG will join NYSE Live to share the results of a new survey that looks at how employees are using AI in the workplace.
  • The RSAC Conference, focusing on cybersecurity innovation and AI-driven defense, kicks off today from San Francisco.

For market insights, IPO activity, and today's opening bell, download the NYSE TV app at tv.nyse.com

Opening Bell
Copa Airlines (NYSE: CPA) celebrates 20th listing anniversary.

Closing Bell
Jacobs (NYSE: J) hosts global executive leadership team meeting for 180 leaders in Midtown and visiting the NYSE.

Click here to download the NYSE TV App

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-alto-neuroscience-raises-120-million-to-fund-development-of-alto-207-302722038.html

SOURCE New York Stock Exchange

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Alto Neuroscience announce about the $120 million financing on March 23, 2026?

Alto Neuroscience announced a $120 million private placement to advance ALTO-207 development. According to Alto Neuroscience, the financing is intended to help match patients with appropriate psychiatric medications and support clinical development activities.

When will Alto Neuroscience CFO Nick Smith appear on NYSE Live to discuss the financing?

Nick Smith will join NYSE Live on March 23, 2026 to discuss the private placement. According to Alto Neuroscience, the appearance will cover the use of proceeds and how financing supports ALTO-207 development plans.

How does the $120 million private placement affect Alto Neuroscience's development of ALTO-207?

The financing is intended to fund advancement of ALTO-207 in psychiatric drug development. According to Alto Neuroscience, proceeds will be used to accelerate clinical and development activities tied to matching patients to medications.

Where can investors watch the Alto Neuroscience discussion on NYSE Live on March 23, 2026?

Investors can view the segment on NYSE Live / NYSE TV on March 23, 2026. According to NYSE, the pre-market update and live interviews are available via the NYSE TV app and website.

Did the March 23, 2026 NYSE pre-market update include other market news affecting NYSE: J?

Yes, the pre-market update covered wider market moves and corporate notes including Jacobs (NYSE: J) hosting a global leadership meeting. According to NYSE, the update also mentioned market reactions and conference coverage.

What investor information did the NYSE pre-market update provide on March 23, 2026?

The NYSE pre-market update provided market context, corporate appearances, and event coverage for March 23, 2026. According to NYSE, it included trading-floor insights, company interviews, IPO activity, and opening bell information.

Keep reading